Open Access Highly Accessed Email this article to a friend

Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study

Gerd R Burmester*, Marco Matucci-Cerinic, Xavier Mariette, Francisco Navarro-Blasco, Sonja Kary, Kristina Unnebrink and Hartmut Kupper

Arthritis Research & Therapy 2014, 16:R24  doi:10.1186/ar4452

Fields marked * are required

Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive Arthritis Research & Therapy's emails?